Ataxia Telangiectasia (A-T) Trial Launch
March 23, 2022, marks the official launch of the Ataxia Telangiectasia (A-T) trial.
Thank you to the multidisciplinary efforts of Dr David Coman, Professor Martin Lavin and their teams for their tireless pursuit to find a new treatment option for children with A-T.
To the families impacted by this genetic condition and organisations such as BrAshA-T Ataxia-Telangiectasia and Rare Voices Australia – this is for you!
Greg Hunt MP, we are grateful for your heartfelt support and the $2.46 million grant received from the Medical Research Future Fund.
None of this would be possible without all of you.
Find out more about A-T and the ongoing trial: http://ow.ly/JmHA50IpVsG
Or support us by making a donation today: http://ow.ly/fbt950IpVta
-
Category
No comments found